DZ2418A1 - Procédé de préparation d'éprosartan - Google Patents

Procédé de préparation d'éprosartan

Info

Publication number
DZ2418A1
DZ2418A1 DZ980028A DZ980028A DZ2418A1 DZ 2418 A1 DZ2418 A1 DZ 2418A1 DZ 980028 A DZ980028 A DZ 980028A DZ 980028 A DZ980028 A DZ 980028A DZ 2418 A1 DZ2418 A1 DZ 2418A1
Authority
DZ
Algeria
Prior art keywords
preparing eprosartan
eprosartan
preparing
Prior art date
Application number
DZ980028A
Other languages
English (en)
French (fr)
Inventor
Richard T Matsuoka
Peng Liu
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of DZ2418A1 publication Critical patent/DZ2418A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DZ980028A 1997-02-14 1998-02-11 Procédé de préparation d'éprosartan DZ2418A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3819697P 1997-02-14 1997-02-14

Publications (1)

Publication Number Publication Date
DZ2418A1 true DZ2418A1 (fr) 2003-06-26

Family

ID=21898590

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980028A DZ2418A1 (fr) 1997-02-14 1998-02-11 Procédé de préparation d'éprosartan

Country Status (41)

Country Link
US (2) US6294675B1 (de)
EP (1) EP0973769B1 (de)
JP (1) JP4227671B2 (de)
KR (1) KR100551667B1 (de)
CN (1) CN1093128C (de)
AP (1) AP1202A (de)
AR (1) AR011126A1 (de)
AT (1) ATE274511T1 (de)
AU (1) AU730162B2 (de)
BG (1) BG63970B1 (de)
BR (1) BRPI9808642B8 (de)
CA (1) CA2281471C (de)
CO (1) CO4950549A1 (de)
CY (1) CY2551B1 (de)
CZ (1) CZ296543B6 (de)
DE (1) DE69825880T2 (de)
DK (1) DK0973769T3 (de)
DZ (1) DZ2418A1 (de)
EA (1) EA001761B1 (de)
EG (1) EG23780A (de)
ES (1) ES2224358T3 (de)
HK (1) HK1026206A1 (de)
HU (1) HU228098B1 (de)
ID (1) ID23155A (de)
IL (4) IL143785A (de)
IN (1) IN188000B (de)
MA (1) MA24472A1 (de)
MY (1) MY120024A (de)
NO (1) NO317761B1 (de)
NZ (1) NZ337182A (de)
OA (1) OA11086A (de)
PE (1) PE59799A1 (de)
PL (1) PL192837B1 (de)
PT (1) PT973769E (de)
SA (1) SA98190146B1 (de)
SI (1) SI0973769T1 (de)
SK (1) SK285125B6 (de)
TR (1) TR199901935T2 (de)
UA (1) UA57060C2 (de)
WO (1) WO1998035962A1 (de)
ZA (1) ZA981208B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.
US6630498B2 (en) * 1997-08-06 2003-10-07 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its preparation and formulation
IL140905A0 (en) * 1998-07-20 2002-02-10 Smithkline Beecham Corp Bioenhanced formulations comprising eprosartan in oral solid dosage form
US20060099230A1 (en) * 2004-11-10 2006-05-11 Chin-Chih Chiang Novel formulations of eprosartan with enhanced bioavailability
WO2008078330A1 (en) * 2006-12-27 2008-07-03 Hetero Drugs Limited Improved process for eprosartan
RU2453536C2 (ru) * 2007-10-22 2012-06-20 Оркид Рисерч Лабораториз Лимитед Ингибиторы гистондезацетилазы
CN101215284B (zh) * 2007-12-31 2010-10-13 浙江华海药业股份有限公司 一种改进的依普罗沙坦的制备方法
WO2011004384A2 (en) 2009-06-05 2011-01-13 Glochem Industries Limited Process for the preparation of eprosartan
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
DE69034103T2 (de) 1989-06-14 2004-07-15 Smithkline Beecham Corp. Imidazoalkensäure
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
AR011126A1 (es) * 1997-02-14 2000-08-02 Smithkline Beecham Corp Procedimiento para preparar eprosartano y compuestos intermediarios.

Also Published As

Publication number Publication date
AP1202A (en) 2003-09-02
DK0973769T3 (da) 2004-12-13
AU6273298A (en) 1998-09-08
MA24472A1 (fr) 1998-10-01
SA98190146B1 (ar) 2006-08-20
NO993912L (no) 1999-08-13
AU730162B2 (en) 2001-03-01
HK1026206A1 (en) 2000-12-08
ID23155A (id) 2000-03-23
BG63970B1 (bg) 2003-08-29
JP4227671B2 (ja) 2009-02-18
TR199901935T2 (xx) 1999-12-21
EA199900741A1 (ru) 2000-02-28
ES2224358T3 (es) 2005-03-01
CA2281471C (en) 2007-04-24
IL143784A0 (en) 2002-04-21
JP2001511808A (ja) 2001-08-14
AP9901619A0 (en) 1999-09-30
PL192837B1 (pl) 2006-12-29
EP0973769B1 (de) 2004-08-25
CN1247538A (zh) 2000-03-15
BG103649A (en) 2000-06-30
KR20000071008A (ko) 2000-11-25
CN1093128C (zh) 2002-10-23
SK108699A3 (en) 2000-05-16
IL131310A0 (en) 2001-01-28
EP0973769A4 (de) 2001-01-24
SI0973769T1 (en) 2004-12-31
EA001761B1 (ru) 2001-08-27
BR9808642A (pt) 2000-05-23
SK285125B6 (sk) 2006-06-01
IL143784A (en) 2005-05-17
DE69825880T2 (de) 2005-09-08
HUP0001813A3 (en) 2001-07-30
DE69825880D1 (de) 2004-09-30
EP0973769A1 (de) 2000-01-26
CY2551B1 (en) 2008-07-02
IL143783A (en) 2005-05-17
NZ337182A (en) 2001-04-27
NO993912D0 (no) 1999-08-13
CZ285199A3 (cs) 2000-02-16
US6458963B1 (en) 2002-10-01
CZ296543B6 (cs) 2006-04-12
PE59799A1 (es) 1999-08-06
ATE274511T1 (de) 2004-09-15
CA2281471A1 (en) 1998-08-20
BR9808642B1 (pt) 2013-11-26
MY120024A (en) 2005-08-30
PT973769E (pt) 2004-11-30
IN188000B (de) 2002-08-03
HU228098B1 (en) 2012-10-29
US6294675B1 (en) 2001-09-25
IL143785A (en) 2004-12-15
HUP0001813A2 (hu) 2001-06-28
UA57060C2 (uk) 2003-06-16
IL143785A0 (en) 2002-04-21
EG23780A (en) 2007-08-13
IL131310A (en) 2003-02-12
CO4950549A1 (es) 2000-09-01
WO1998035962A1 (en) 1998-08-20
BRPI9808642B8 (pt) 2021-05-25
AR011126A1 (es) 2000-08-02
IL143783A0 (en) 2002-04-21
OA11086A (en) 2003-03-13
KR100551667B1 (ko) 2006-02-13
NO317761B1 (no) 2004-12-13
US20020028951A1 (en) 2002-03-07
PL335074A1 (en) 2000-04-10
ZA981208B (en) 1998-11-12

Similar Documents

Publication Publication Date Title
DZ2370A1 (fr) Procédé de préparation d'hydrocarbures
DZ2851A1 (fr) Procédé d'émulsification.
FR2749778B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
FR2764211B1 (fr) Procede de preparation de catalyseurs d'hydrotraitement
CY2551B1 (en) Process for preparing eprosartan
EG22337A (en) Process for preparing novel pharmaceutical compounds
CY2555B1 (en) Process for preparing eprosartan
DZ1946A1 (fr) Procédé pour la préparation de supports.
FR2764883B1 (fr) Procede de fabrication d'hydrofluoroalcanes
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.
FR2694211B1 (fr) Procédé d'élimination de catalyseur.
FR2708266B1 (fr) Procédé de préparation d'alcanesulfonamides.
FR2754816B1 (fr) Procede de purification d'hydrogenochlorofluoroethanes
DZ2619A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoïques substitués.
IL131205A0 (en) Process for preparing pharmaceutical compounds
DZ2423A1 (fr) Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués.
DZ2770A1 (fr) Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
FR2719580B1 (fr) Procédé de préparation d'octadiénols.
FR2721028B1 (fr) Procédé de synthèse d'halogénoalkylferrocènes.
MA24258A1 (fr) Procede de monoacylation d'hydoxytaxanes
FR2717475B1 (fr) Procédé de préparation d'aryltétrazoles.
SG72731A1 (en) Process for preparing optically active trans-3-phenylglycidamide compounds
FR2736635B1 (fr) Procede de preparation d'alpha,omega-bromochloroalcanes
FR2718131B1 (fr) Procédé de préparation d'octadiénols.